Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 8.580
- +0.870+11.28%
Close Feb 14 16:00 ET
726.42MMarket Cap-3.49P/E (TTM)
8.870High7.820Low1.41MVolume7.820Open7.710Pre Close12.03MTurnover2.31%Turnover RatioLossP/E (Static)84.66MShares19.34052wk High1.43P/B522.51MFloat Cap4.30552wk Low--Dividend TTM60.90MShs Float78.000Historical High--Div YieldTTM13.62%Amplitude4.305Historical Low8.543Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Joan Nickerson
- Chief Administrative Officer
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Alexander G. Cumbo
- Independent Director
- 405.88K
- Michael F. Maclean
- Independent Director
- 521.07K
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Jodie P. Morrison
- Independent Director
- --
- Lonnel Coats
- Independent Director
- 407.38K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
